⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BioCryst Pharmaceuticals Inc

$8.67
+0.06 (+0.70%)

Volume:

1.691M ($14.66M)

Market Capitalization:

$2.22B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

BioCryst Pharmaceuticals Market Segments

Regular Trading Hours

+0.25(+2.91%)
Open$8.43
Close$8.67
Low$8.31
Low Change-0.12 (-1.36%)
High$8.86
High Change+0.44 (+5.16%)
Range$0.55
Volume1.642M
Dollar Volume$14.24M

Premarket

+0.19(+2.29%)
Open$8.31
Close$8.50
Low$8.31
Low Change0.00 (0.00%)
High$8.90
High Change+0.59 (+7.10%)
Range$0.59
Volume49.231K
Dollar Volume$418.46K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.10(-1.16%)
Open$8.62
Close$8.52
Low$8.50
Low Change-0.12 (-1.39%)
High$8.64
High Change+0.02 (+0.23%)
Range$0.14
Volume1.057M
Dollar Volume$9.01M

Regular Trading Hours Yesterday

+0.38(+4.62%)
Open$8.23
Close$8.61
Low$8.19
Low Change-0.04 (-0.49%)
High$8.62
High Change+0.39 (+4.74%)
Range$0.43
Volume5.433M
Dollar Volume$46.78M

Premarket Yesterday

*No Trades in Segment

BioCryst Pharmaceuticals Top Trades

BioCryst Pharmaceuticals's top trade so far today returned +7.10%, while the top short trade returned -6.63%.

BioCryst Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$8.45
10 Day Moving Average (SMA10)$8.14
20 Day Moving Average (SMA20)$8.14
50 Day Moving Average (SMA50)$8.58
100 Day Moving Average (SMA100)$9.10
200 Day Moving Average (SMA200)$8.76

BioCryst Pharmaceuticals Statistics

Average Volume (30 Days)5.15M
P/E Ratio (Current)-5.66
EPS (Current)-$1.51
Dividend Yield0.00%
Free Cash Flow$373.38M
Cash Ratio0.74
Current Ratio2.32
Quick Ratio2.29
Debt to Equity-1.81
Enterprise Value$2.85B
EV to EBITDA-9.16
EV to Sales3.03
Price to Book-4.81
Price to Cash Flow5.81
Price to Free Cash Flow5.85
Price to Sales2.32
Return on Assets-0.69%
Return on Equity0.85%

BioCryst Pharmaceuticals Stock Splits

There have been no stock splits for BioCryst Pharmaceuticals (BCRX).

BioCryst Pharmaceuticals Dividends

There have been no dividends for BioCryst Pharmaceuticals (BCRX).